Diurnal is a European, UK-headquartered specialty pharmaceutical company dedicated to developing hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions, including Congenital Adrenal Hyperplasia, Adrenal Insufficiency, Hypogonadism and Hypothyroidism.
Country of Incorporation
The Company was incorporated in England and Wales on 28 October 2015 under the Act as Project Diurnal Limited with registered number 9846650. The Company was re-registered as a public limited company, Diurnal Group PLC, on 4th December, 2015. The Company is subject to the United Kingdom City Code on Takeovers and Mergers.
Registered Office and Corporate Headquarters
Cardiff MediCentre, Heath Park, Cardiff, CF14 4UJ, UK.
Tel: +44 (0)2920 682 069